Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing-Reference-Cited by-同舟云学术

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

Published:2017-05-05 Issue:34 Volume:8 Page:56338-56350
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Majumder Muntasir Mamun¹,Silvennoinen Raija²³,Anttila Pekka³,Tamborero David⁴,Eldfors Samuli¹,Yadav Bhagwan¹,Karjalainen Riikka¹,Kuusanmäki Heikki¹,Lievonen Juha³,Parsons Alun¹,Suvela Minna¹,Jantunen Esa²,Porkka Kimmo³⁵,Heckman Caroline A.¹

Affiliation:

1. Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland

2. Department of Medicine, Kuopio University Hospital, Kuopio, Finland

3. Department of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland

4. Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain

5. Hematology Research Unit, University of Helsinki, Helsinki, Finland

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omic and functional screening reveal targetable vulnerabilities inTP53mutated multiple myeloma;2024-08-23

2. Robust scoring of selective drug responses for patient-tailored therapy selection;Nature Protocols;2023-11-23

3. Using Proteomics Data to Identify Personalized Treatments in Multiple Myeloma: A Machine Learning Approach;International Journal of Molecular Sciences;2023-10-25

4. Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures;Cancers;2023-07-25

5. Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma;Nature Cancer;2023-04-20